Grifols closes 29 US plasma donation centers in network optimization

  • Grifols announced closure of 29 U.S. plasma donation centers as part of a targeted network optimization.
  • Operations will be consolidated into higher-performing locations to lift productivity per center, improve utilization, support margin-led EBITDA growth.
  • Implementation is scheduled over coming weeks, with donors redirected to nearby Grifols sites during a short transition period.
  • Grifols expects overall U.S. plasma collection volumes to grow despite smaller footprint, driven by higher productivity.
  • EMA approval of Egyptian source plasma is expected to reduce reliance on U.S. plasma for ex-U.S. markets, freeing U.S. collections to focus on domestic demand.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grifols SA published the original content used to generate this news brief on April 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.